The Center for Contemporary Sciences (CCS) and BICO formalized a strategic partnership aiming at modernizing drug development and replacing animal testing with more human-relevant methods. CCS is a scientific and advocacy organization championing human-relevant methodologies in medical research. BICO is the bioconvergence company spearheading life sciences and medical technologies to shape the future of health.

The two organizations will work closely to support the FDA Modernization Act of 2021 and combine efforts on other initiatives to improve human health and advance personalized medicine. The bill will accelerate the discovery process, stimulate innovation, and lower the costs of new life-saving treatments. It is expected that the combined efforts of BICO and CCS will bolster the development and use of human-relevant technologies.

Such technologies include sophisticated tissue models, 3D bioprinting, Organ Chips, and microfluidics platforms.